Combined Anthrax and Sheep Pox Vaccine, Production and Immunization Trial in Sudan

Simple item page
dc.FacultyEndemic Diseasesen_US
dc.contributor.authorMukhtar, Moawia M.
dc.contributor.authorAhmed, Abbas Mohamed
dc.date2007
dc.date.accessioned2015-11-23T10:28:45Z
dc.date.available2015-11-23T10:28:45Z
dc.date.issued2015-11-23
dc.date.submitted2015
dc.description.abstractAn anthrax and sheep pox combined vaccine was made in a lyophilized form by mixing concentrated live spores of Bacillus anthracis (Sterne strain) of known count with sheep pox virus (0240 vaccine strain) of a known titer. It induced protection against anthrax in guinea pigs and sheep pox diseases in sheep after challenge with virulent Bacillus anthracis and sheep pox virus, respectively. The vaccine was found stable after 15 month of preservation at -20°C.en_US
dc.identifier.urihttp://khartoumspace.uofk.edu/123456789/17268
dc.publisheruniversity of khartoumen_US
dc.subjectAnthrax, sheep, vaccine, immunization, production, Sudanen_US
dc.titleCombined Anthrax and Sheep Pox Vaccine, Production and Immunization Trial in Sudanen_US
dc.typePublicationen_US

Files

Collections

Medical and Health
Load more